20.34
price up icon0.99%   0.20
after-market Handel nachbörslich: 20.34
loading

Finanzdaten der Viridian Therapeutics Inc-Aktie (VRDN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
0.00%
0.072
0.072 0.072 0.072 0.098
Operating Expenses
21.78%
55.97
71.55 51.30 59.35 72.57
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
21.78%
55.97
71.55 51.30 59.35 72.57
Operating Income/Loss
21.80%
-55.90
-71.48 -51.22 -59.27 -72.47
Nonoperating Income/Loss
59.27%
7.355
4.618 3.564 4.212 4.322
Income/Loss From Continuing Operations Before Tax
0.00%
0.072
0.072 0.072 -55.06 -68.15
Income/Loss From Continuing Operations After Tax
27.40%
-48.54
-66.86 -47.66 -55.06 -68.15
Net Income/Loss
27.40%
-48.54
-66.86 -47.66 -55.06 -68.15
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,499%
61.10
1.6978 43.65 43.25 42.24
Diluted Average Shares
3,499%
61.10
1.6978 43.65 43.25 42.24
Basic Earnings Per Share
41.04%
-0.79
-1.34 -1.09 -1.27 -1.61
Diluted Earnings Per Share
41.04%
-0.79
-1.34 -1.09 -1.27 -1.61
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):